GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.

Technology, Clinical Trials, Insomnia Corey Hubbard Technology, Clinical Trials, Insomnia Corey Hubbard

The Sandman's New Assistant: AI and the Quest for Better Sleep

Sleep. That elusive, restorative state that we all crave, yet so many struggle to achieve. In our fast-paced, tech-driven world, a good night's rest often feels like a luxury, not a necessity. But what if technology, the very thing that sometimes keeps us up, could also be the key to unlocking better sleep? Enter artificial intelligence (AI), the potential game-changer in our quest for a peaceful slumber.

Read More

The Dawn of Data-Driven Drug Development: Clinical Ink's AI Analytics Dashboard 

The pharmaceutical industry stands at a pivotal juncture, poised to revolutionize clinical trials through the integration of advanced technologies. At the heart of this transformation lies the burgeoning field of clinical trial analytics, a domain leveraging data science, artificial intelligence (AI), and machine learning (ML) to enhance the efficiency, accuracy, and speed of drug development. Clinical Ink's recent unveiling of an AI-powered trial analytics dashboard exemplifies this paradigm shift, offering a sophisticated tool for real-time data visualization, predictive analysis, and actionable insights. This essay will explore the significance of such platforms, delve into the pivotal role of clinical trial analytics scientists, and examine the broader implications for the future of clinical research.

Read More